Clarence Henderson Hale, Age 604787 Aqua Verde Ct, Camarillo, CA 93012

Clarence Hale Phones & Addresses

4787 Aqua Verde Ct, Camarillo, CA 93012 (805) 388-8944

5005 Ladera Vista Dr, Camarillo, CA 93012 (805) 388-8944

Eugene, OR

Saint Louis, MO

Grayslake, IL

East Alton, IL

Ventura, CA

Newbury Park, CA

Show more

Work

Position: Professional/Technical

Emails

Mentions for Clarence Henderson Hale

Clarence Hale resumes & CV records

Resumes

Clarence Hale Photo 18

Director, Research

Location:
Los Angeles, CA
Industry:
Biotechnology
Work:
Amgen
Director, Research
Amgen Mar 2010 - Mar 2014
Principal Scientist
Amgen Mar 2006 - Mar 2010
Senior Scientist
Amgen Mar 2004 - Mar 2006
Scientist
Amgen Mar 2001 - Mar 2004
Associate Scientist Ii
Amgen Jun 1999 - Mar 2001
Associate Scientist I
Abbott Jul 1992 - Jan 1996
Associate Research Pharmacologist
Saint Louis University 1987 - 1992
Senior Research Assistant
Education:
Saint Louis University 1989 - 1992
Master of Science, Masters, Biology
Millikin University 1983 - 1987
Bachelors, Bachelor of Science, Biology
Skills:
Drug Development, Assay Development, Drug Discovery, Biotechnology, Clinical Development, Type 2 Diabetes, Immunology, High Throughput Screening, Small Molecules, Antibodies, Life Sciences, Neuroscience, Biopharmaceuticals, Pharmaceutical Industry, Situational Leadership, Team Leadership, Molecular Biology, Cell Culture, Protein Chemistry, Biochemistry, Cell Biology, Cell, Biomarkers, Oncology, Job Coaching, Management, In Vitro
Interests:
Science and Technology
Environment
Clarence Hale Photo 19

Clarence Hale

Clarence Hale Photo 20

Clarence Hale

Publications & IP owners

Wikipedia

Clarence Hale Photo 21

Clarence Hale

Clarence Hale (April 15, 1848 April 9, 1934) was a United States federal judge. Born in Turner, Maine, Hale received an A.B. from Bowdoin College in 1869 ...

Us Patents

Compounds That Interact With Glucokinase Regulatory Protein For The Treatment Of Diabetes

US Patent:
2012022, Sep 6, 2012
Filed:
Aug 23, 2011
Appl. No.:
13/215914
Inventors:
Kate Ashton - Westlake Village CA, US
Michael David Bartberger - Sherman Oaks CA, US
Yunxin Bo - Thousand Oaks CA, US
Marian C. Bryan - West Hills CA, US
Michael Croghan - Thousand Oaks CA, US
Christopher Harold Fotsch - Thousand Oaks CA, US
Clarence Henderson Hale - Camarillo CA, US
Roxanne Kay Kunz - Santa Monica CA, US
Longbin Liu - Thousand Oaks CA, US
Nobuko Nishimura - West Hills CA, US
Mark H. Norman - Thousand Oaks CA, US
Lewis Dale Pennington - Ventura CA, US
Steve Fong Poon - Woodland Hills CA, US
Markian Myroslaw Stec - Thousand Oaks CA, US
David Joseph St. Jean, JR. - Camarillo CA, US
Nuria A. Tamayo - Newbury Park CA, US
Christopher Michael Tegley - Thousand Oaks CA, US
Kevin Chao Yang - San Gabriel CA, US
Assignee:
AMGEN INC. - Thousand Oaks CA
International Classification:
A61K 31/496
A61P 27/02
A61P 13/12
A61P 25/00
A61P 27/12
A61P 27/06
A61P 3/04
A61P 15/00
C07D 409/12
C07D 295/26
A61K 31/495
C07D 403/12
C07D 401/12
C07D 409/14
A61K 31/506
C07D 213/46
A61K 31/4418
C07C 317/22
A61K 31/10
C07D 405/12
C07D 417/10
C07D 413/14
A61K 31/5377
C07D 498/08
A61K 31/5386
C07D 491/107
C07D 417/14
A61K 31/541
C07D 401/14
C07D 491/048
C07D 471/08
C07D 211/54
A61K 31/451
A61K 31/501
C07D 487/04
A61K 31/4985
C07D 403/04
C07D 491/08
A61P 3/10
US Classification:
5142102, 544379, 51425213, 544383, 51425503, 544371, 51425405, 544360, 51425312, 544295, 51425214, 546344, 514277, 568 32, 514709, 5142541, 544369, 51425402, 51425403, 544121, 5142358, 544105, 5142305, 544372, 51425401, 544370, 544230, 544 582, 5142278, 51425408, 546216, 514327, 544238, 51425202, 544350, 514249, 544357, 51425211, 544367, 514710, 544362, 51425304
Abstract:
The present invention relates to compounds of Formula I, or pharmaceutically acceptable salts thereof,that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.

Treatment Of Bile Acid Disorders

US Patent:
2018028, Oct 4, 2018
Filed:
Sep 30, 2016
Appl. No.:
15/765144
Inventors:
- Thousand Oaks CA, US
Shanaka Stanislaus - Thousand Oaks CA, US
Mei-Hsiu M. Chen - Agoura Hills CA, US
Clarence H. Hale - Camarillo CA, US
International Classification:
A61K 38/18
A61P 1/00
A61P 1/16
Abstract:
The invention relates method of treating a patient in need thereof with a long acting agonist to the FGF21 signaling pathway. In a particular embodiment, the invention relates to the use of molecules that stimulate the FGF21 signaling pathway, such as long acting FGF21 polypeptides or agonist antibodies, to treat disorders or diseases associated with excess bile acid. The invention further relates to pharmaceutical formulations and dosing of long acting agonists of the FGF21 signaling pathway suitable for treating bile acid related disorders.

Isbn (Books And Publications)

The Stone House Murder, And Other New England Tales

Author:
Clarence E. Hale
ISBN #:
0871060906

Tales From A New England Farm

Author:
Clarence E. Hale
ISBN #:
0871061376

Let'S Study Greek

Author:
Clarence Benjamin Hale
ISBN #:
0802446663

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.